Ji M - Search Results

1

YTHDF1 Promotes Gastric Carcinogenesis by Controlling Translation of FZD7.

Pi J, Wang W, Ji M, Wang X, Wei X, Jin J, Liu T, Qiang J, Qi Z, Li F, Liu Y, Ma Y, Si Y, Huo Y, Gao Y, Chen Y, Dong L, Su R, Chen J, Rao S, Yi P, Yu S, Wang F, Yu J. Pi J, et al. Among authors: ji m. Cancer Res. 2021 May 15;81(10):2651-2665. doi: 10.1158/0008-5472.CAN-20-0066. Epub 2020 Aug 11. Cancer Res. 2021. PMID: 32788173

2

LB-1 Exerts Antitumor Activity in Pancreatic Cancer by Inhibiting HIF-1α and Stat3 Signaling.

Niu F, Li Y, Lai FF, Ni L, Ji M, Jin J, Yang HZ, Wang C, Zhang DM, Chen XG. Niu F, et al. Among authors: ji m. J Cell Physiol. 2015 Sep;230(9):2212-23. doi: 10.1002/jcp.24949. J Cell Physiol. 2015. PMID: 25655308

3

Poly (ADP-ribose) polymerases inhibitor, Zj6413, as a potential therapeutic agent against breast cancer.

Zhou Q, Ji M, Zhou J, Jin J, Xue N, Chen J, Xu B, Chen X. Zhou Q, et al. Among authors: ji m. Biochem Pharmacol. 2016 May 1;107:29-40. doi: 10.1016/j.bcp.2016.02.015. Epub 2016 Feb 24. Biochem Pharmacol. 2016. PMID: 26920250

4

Chlorogenic acid inhibits glioblastoma growth through repolarizating macrophage from M2 to M1 phenotype.

Xue N, Zhou Q, Ji M, Jin J, Lai F, Chen J, Zhang M, Jia J, Yang H, Zhang J, Li W, Jiang J, Chen X. Xue N, et al. Among authors: ji m. Sci Rep. 2017 Jan 3;7:39011. doi: 10.1038/srep39011. Sci Rep. 2017. PMID: 28045028 Free PMC article.

5

Nicousamide protects kidney podocyte by inhibiting the TGFβ receptor II phosphorylation and AGE-RAGE signaling.

Zhang S, Wang D, Xue N, Lai F, Ji M, Jin J, Chen X. Zhang S, et al. Among authors: ji m. Am J Transl Res. 2017 Jan 15;9(1):115-125. eCollection 2017. Am J Transl Res. 2017. PMID: 28123638 Free PMC article.

6

Validating a Selective S1P₁ Receptor Modulator Syl930 for Psoriasis Treatment.

Ji M, Xue N, Lai F, Zhang X, Zhang S, Wang Y, Jin J, Chen X. Ji M, et al. Biol Pharm Bull. 2018 Apr 1;41(4):592-596. doi: 10.1248/bpb.b17-00939. Epub 2018 Feb 7. Biol Pharm Bull. 2018. PMID: 29415945 Free article.

7

The Development of a Biotinylated NAD⁺-Applied Human Poly(ADP-Ribose) Polymerase 3 (PARP3) Enzymatic Assay.

Ji M, Wang L, Xue N, Lai F, Zhang S, Jin J, Chen X. Ji M, et al. SLAS Discov. 2018 Jul;23(6):545-553. doi: 10.1177/2472555218767843. Epub 2018 Apr 20. SLAS Discov. 2018. PMID: 29676938 Free article.

8

Discovery and Optimization of 2-Amino-4-methylquinazoline Derivatives as Highly Potent Phosphatidylinositol 3-Kinase Inhibitors for Cancer Treatment.

Lin S, Wang C, Ji M, Wu D, Lv Y, Zhang K, Dong Y, Jin J, Chen J, Zhang J, Sheng L, Li Y, Chen X, Xu H. Lin S, et al. Among authors: ji m. J Med Chem. 2018 Jul 26;61(14):6087-6109. doi: 10.1021/acs.jmedchem.8b00416. Epub 2018 Jul 9. J Med Chem. 2018. PMID: 29927604

9

CAT₃, a prodrug of 13a(S)-3-hydroxyl-6,7-dimethoxyphenanthro[9,10-b]-indolizidine, circumvents temozolomide-resistant glioblastoma via the Hedgehog signaling pathway, independently of O⁶-methylguanine DNA methyltransferase expression.

Ji M, Wang L, Chen J, Xue N, Wang C, Lai F, Wang R, Yu S, Jin J, Chen X. Ji M, et al. Onco Targets Ther. 2018 Jun 25;11:3671-3684. doi: 10.2147/OTT.S163535. eCollection 2018. Onco Targets Ther. 2018. PMID: 29983575 Free PMC article.

10

A novel PI3K/mTOR dual inhibitor XH002 exhibited robust antitumor activity in NSCLC.

Lv Y, Du T, Ji M, Wang C, Lin S, Xue N, Jin J, Xu H, Chen X. Lv Y, et al. Among authors: ji m. J Drug Target. 2019 Apr;27(4):451-459. doi: 10.1080/1061186X.2018.1542533. Epub 2018 Nov 11. J Drug Target. 2019. PMID: 30381967

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,208 results

Search Page